1. Home
  2. BDTX vs XNET Comparison

BDTX vs XNET Comparison

Compare BDTX & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • XNET
  • Stock Information
  • Founded
  • BDTX 2014
  • XNET 2003
  • Country
  • BDTX United States
  • XNET China
  • Employees
  • BDTX N/A
  • XNET N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • XNET Computer Software: Prepackaged Software
  • Sector
  • BDTX Health Care
  • XNET Technology
  • Exchange
  • BDTX Nasdaq
  • XNET Nasdaq
  • Market Cap
  • BDTX 144.9M
  • XNET 131.8M
  • IPO Year
  • BDTX 2020
  • XNET 2014
  • Fundamental
  • Price
  • BDTX $2.20
  • XNET $2.12
  • Analyst Decision
  • BDTX Strong Buy
  • XNET
  • Analyst Count
  • BDTX 4
  • XNET 0
  • Target Price
  • BDTX $15.50
  • XNET N/A
  • AVG Volume (30 Days)
  • BDTX 1.2M
  • XNET 111.5K
  • Earning Date
  • BDTX 03-11-2025
  • XNET 03-13-2025
  • Dividend Yield
  • BDTX N/A
  • XNET N/A
  • EPS Growth
  • BDTX N/A
  • XNET 146.84
  • EPS
  • BDTX N/A
  • XNET 0.23
  • Revenue
  • BDTX N/A
  • XNET $359,611,000.00
  • Revenue This Year
  • BDTX N/A
  • XNET N/A
  • Revenue Next Year
  • BDTX N/A
  • XNET N/A
  • P/E Ratio
  • BDTX N/A
  • XNET $9.37
  • Revenue Growth
  • BDTX N/A
  • XNET 99.13
  • 52 Week Low
  • BDTX $1.91
  • XNET $1.45
  • 52 Week High
  • BDTX $7.66
  • XNET $2.41
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 46.41
  • XNET 54.45
  • Support Level
  • BDTX $2.02
  • XNET $1.99
  • Resistance Level
  • BDTX $2.33
  • XNET $2.17
  • Average True Range (ATR)
  • BDTX 0.18
  • XNET 0.10
  • MACD
  • BDTX 0.03
  • XNET 0.00
  • Stochastic Oscillator
  • BDTX 38.16
  • XNET 83.02

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

Share on Social Networks: